2025 International Fall Summit
October 15, 2025 | 12:00 PM EST
Putting Gilteritinib (Xospata®) for Relapsed/Refractory Acute Myeloid Leukemia (AML) into Action
Download PQI pdf 2.7MB
Last Updated: April 1, 2022